XIFLAM
"XIFLAM" is a word mark owned by InflammX Therapeutics, Inc., filed at the USPTO on December 31, 2025. It has been allowed and covers class 5 (Pharmaceuticals).
- Status
- Allowed
- Since July 21, 2026
- Filed
- December 31, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99573021
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns XIFLAM
The owner and representative on file with the office.
Owner
InflammX Therapeutics, Inc.
San Diego, United States
Representative
Sophie B. Anger
Bausch + Lomb
What the mark covers
The products and services XIFLAM is filed for, grouped by Nice class.
Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of eye diseases and conditions
What has happened so far
Steps recorded by the USPTO, newest first.
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
5 earlier steps on the official record.
About XIFLAM
Who owns the trademark "XIFLAM"?
The USPTO trademark "XIFLAM" (application 99573021) is owned by InflammX Therapeutics, Inc.
What is the status of "XIFLAM"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull XIFLAM and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b80-5ec1-72eb-bc40-5de57e095a1a
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b80-5ec1-72eb-bc40-5de57e095a1a",
"object": "trademark",
"mark_text": "XIFLAM",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99573021",
"filing_date": "2025-12-31",
"nice_classes": [
5
],
"owners": [
{
"name": "InflammX Therapeutics, Inc.",
"entity_id": null
}
]
}